The First Affiliated Hospital With Nanjing Medical University
Clinical trials sponsored by The First Affiliated Hospital With Nanjing Medical University, explained in plain language.
-
New pacing technique may shield heart from damage in block patients
Disease control OngoingThis study tests if a newer pacing method called left bundle branch pacing (LBBP) is better than standard right ventricular pacing (RVP) at preserving heart function in 683 adults with atrioventricular block (a type of heart block). Participants will be randomly assigned to one o…
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New heart pacing strategy could cut defibrillator need
Disease control OngoingThis study tests whether a special heart pacing technique (left bundle branch pacing) combined with standard heart failure drugs can improve heart function better than drugs alone. It includes 50 adults with non-ischemic heart failure and a specific heart block. The main goal is …
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Blood test may spot hidden cancer cells, guiding smarter treatment for esophageal cancer
Disease control ENROLLING_BY_INVITATIONThis study looks at whether a blood test that finds tiny traces of cancer DNA (called ctDNA-MRD) can help doctors decide who needs more treatment after standard chemoradiation for advanced esophageal cancer. About 65 people with unresectable cancer will get extra immunotherapy an…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New tetracycline drugs take on superbugs in Real-World trial
Disease control ENROLLING_BY_INVITATIONThis real-world study is testing two neotetracycline drugs, eravacycline and tigecycline, in 300 adults with drug-resistant Gram-negative bacterial infections. Researchers will track how well the drugs clear the infection and monitor for side effects. The goal is to see if these …
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug offers hope for rosacea sufferers with burning pain
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether Cligabalin (HSK16149) can help people with a type of rosacea that causes severe burning and tingling on the face. It includes 60 adults whose redness and discomfort did not improve with standard treatments. The main goal is to see if the drug reduces f…
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Lung cancer and scarred lungs: a dangerous duo under the microscope
Knowledge-focused OngoingThis study examines how well immunotherapy works for people with both lung cancer and pulmonary fibrosis (scarred lungs). Researchers will compare 200 patients with both conditions to similar patients without scarring, tracking survival and side effects. They also analyze tumor t…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC